Advances in Endocrine Surgery
Recent changes in the landscape of endocrine surgery include a shift from total thyroidectomy for almost all patients with papillary thyroid cancer to the incorporation of thyroid lobectomy for well-selected patients with low-risk disease; minimally invasive parathyroidectomy with, and potentially without, intraoperative parathyroid hormone monitoring for patients with well-localized primary hyperparathyroidism; improvement in the management of parathyroid cancer with the incorporation of immune checkpoint blockade and/or targeted therapies; and the incorporation of minimally invasive techniques in the management of patients with benign tumors and selected secondary malignancies of the adrenal gland.
Source: Surgical Oncology Clinics of North America - Category: Surgery Authors: Michael S. Lui, Aditya S. Shirali, Bernice L. Huang, Sarah B. Fisher, Nancy D. Perrier Source Type: research
More News: Cancer | Cancer & Oncology | Hormones | Hyperparathyroidism | Parathyroid Cancer | Parathyroidectomy | Surgery | Thyroid | Thyroid Cancer | Thyroidectomy